A solid controlled-release pharmaceutical formulation containing alfuzosin hydrochloride and the use thereof in the treatment of prostate hypertrophy.
They are palliative for conditions in urinary tracts (cystitis, pyelonephritis, prostate hypertrophy, blennorrhea urethritis).
